In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vibha Sharma

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She joined Scrip Regulatory Affairs in September 2010 and has since then been at the center of deciding and writing news on important regulatory issues affecting the pharma and medtech sectors and explaining their implications for the industry.

Her fields of interest include the EU Pharmacovigilance legislation and the EU Paediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.

Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.

Advertisement
Set Alert for Articles By Vibha Sharma

Latest From Vibha Sharma

EU Takes Dispute With Turkey On Localization Policy To Next Level

After unsuccessful negotiations with Turkey on its discriminatory policies against foreign drug producers, the EU has asked the World Trade Organization to set up a dispute settlement panel to resolve the matter.
Europe Turkey

EU Warns Of Birth Defect Risks With Anti-Nausea Drug Ondansetron

Sponsors of medicines containing ondansetron in the EU have been given two months to update their product information to state that the drug should not be used in early pregnancy. 
Europe Drug Safety

End Of Road For ‘Too Complex’ EU Pilot Program On Splitting Marketing Licenses

EU regulators have pulled the plug on a pilot program on splitting mutual recognition and decentralized procedure licences. Instead of promoting harmonization of marketing authorizations across the EU and helping companies with their marketing strategies, it has led to more problems.

Europe Generic Drugs

End Of Road For ‘Too Complex’ EU Pilot On Splitting Marketing Licenses

EU regulators have pulled the plug on a pilot program on splitting mutual recognition and decentralized procedure licences. Instead of promoting harmonization of marketing authorizations across the EU and helping companies with their marketing strategies, it has led to more problems.
Europe Generic Drugs

Canada Consults On Customized Rules For Approving Unique Devices, Drugs

Health Canada is inviting suggestions from stakeholders as it works on implementing a flexible approach for authorizing complex and novel health products. The regulator also draws up new clinical trial rules.

Canada Clinical Trials

Canada Consults On Customized Rules For Approving Unique Drugs, Devices

Health Canada is inviting suggestions from stakeholders as it works on implementing a flexible approach for authorizing complex and novel health products. The regulator also draws up new clinical trial rules.
Canada Clinical Trials
See All
Advertisement
UsernamePublicRestriction

Register